Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Healthcare investment fund founded:

This article was originally published in Clinica

Executive Summary

Henry Wendt, the retired SmithKline Beecham chairman who piloted its 1989 merger, is one of a line-up of healthcare managers who have set up the Finisterre fund, a private equity investment fund working exclusively in the healthcare products industry. Finisterre intends to acquire "foundation" companies and then to build each of them through strategic acquisition of related companies and products. By "foundation" company the group means one with at least $50 million in revenue, with operating profits and products essential to patient health. The fund says it can make large acquisitions of up to $1,000 million.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT093333

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel